12 November 2020

Rigvir Group is participating in "BIO Partnering at JPM" on January 11-15, 2021. BIO is offering access to BIO One-on-One Partnering service during 2021 J.P. Morgan Healthcare Conference (JPM) week. This unique industry service allows to connect with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders.
Rigvir group will participate in this event together with the partner - french company Strad Healthcare, represented by its CEO PhD Stephane Altaba, who is leading Uveal melanoma project.
More information: https://www.bio.org/events/bio-partnering-jpm